Recombinant multi-species Cathepsin D/CTSD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Cathepsin D/CTSD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the A1 family of peptidases. The encoded preproprotein is proteolytically processed to generate multiple protein products. These products include the cathepsin D light and heavy chains, which heterodimerize to form the mature enzyme. This enzyme exhibits pepsin-like activity and plays a role in protein turnover and in the proteolytic activation of hormones and growth factors. Mutations in this gene play a causal role in neuronal ceroid lipofuscinosis-10 and may be involved in the pathogenesis of several other diseases, including breast cancer and possibly Alzheimer's disease. [provided by RefSeq, Nov 2015]
The Alternative Names of target: CATD,CD,CLN10,CPSD,CTSD,CatD,Cathepsin D,Ctsd,HEL-S-130P

Target products collectionGo to Cathepsin D/CTSD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T67102-Ag-1/ GM-Tg-hg-T67102-Ag-2 Human Cathepsin D/CTSD protein Human
GM-Tg-rg-T67102-Ag-1/ GM-Tg-rg-T67102-Ag-2 Rat Cathepsin D/CTSD protein Rat
GM-Tg-mg-T67102-Ag-1/ GM-Tg-mg-T67102-Ag-2 Mouse Cathepsin D/CTSD protein Mouse
GM-Tg-cynog-T67102-Ag-1/ GM-Tg-cynog-T67102-Ag-2 Cynomolgus/Rhesus macaque Cathepsin D/CTSD protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T67102-Ag-1/ GM-Tg-felg-T67102-Ag-2 Feline Cathepsin D/CTSD protein Feline
GM-Tg-cang-T67102-Ag-1/ GM-Tg-cang-T67102-Ag-2 Canine Cathepsin D/CTSD protein Canine
GM-Tg-bovg-T67102-Ag-1/ GM-Tg-bovg-T67102-Ag-2 Bovine Cathepsin D/CTSD protein Bovine
GM-Tg-equg-T67102-Ag-1/ GM-Tg-equg-T67102-Ag-2 Equine Cathepsin D/CTSD protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T67102-Ag-1/ GM-Tg-hg-T67102-Ag-2; GM-Tg-rg-T67102-Ag-1/ GM-Tg-rg-T67102-Ag-2;
GM-Tg-mg-T67102-Ag-1/ GM-Tg-mg-T67102-Ag-2; GM-Tg-cynog-T67102-Ag-1/ GM-Tg-cynog-T67102-Ag-2;
GM-Tg-felg-T67102-Ag-1/ GM-Tg-felg-T67102-Ag-2; GM-Tg-cang-T67102-Ag-1/ GM-Tg-cang-T67102-Ag-2;
GM-Tg-bovg-T67102-Ag-1/ GM-Tg-bovg-T67102-Ag-2; GM-Tg-equg-T67102-Ag-1/ GM-Tg-equg-T67102-Ag-2
Products Name Cathepsin D/CTSD protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Cathepsin D/CTSD
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Cathepsin D/CTSD protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.